<DOC>
	<DOCNO>NCT00392041</DOCNO>
	<brief_summary>The purpose ass efficacy eszopiclone treatment insomnia symptom fibromyalgia . It hypothesize participant receive eszopiclone report great improvement total sleep time , sleep quality , pain , fatigue , physical functioning , emotional distress receive placebo .</brief_summary>
	<brief_title>Eszopiclone Treatment Insomnia Fibromyalgia</brief_title>
	<detailed_description>Fibromyalgia ( FM ) prevalent , debilitate , costly syndrome . Although pathophysiology FM yet well-understood , sleep disturbance prominent feature theory . Eszopiclone approve FDA treatment insomnia , study treatment FMS . The purpose ass efficacy eszopiclone treatment insomnia symptom fibromyalgia ( FMS ) FMS patient . Participants randomly select receive eszopiclone placebo . It hypothesize participant receive eszopiclone report great improvement total sleep time , sleep quality , pain , fatigue , physical functioning , emotional distress receive placebo .</detailed_description>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Eszopiclone</mesh_term>
	<criteria>1 . Male female , age 18 64 . 2 . Meets ACR criterion FMS , determine rheumatological examination medical history review . 3 . Reports sleep maintenance insomnia ( total sleep time &lt; 6.5 hour sleep impairment consist 3 7 night per week month history ) sleep onset latency insomnia ( least 3 7 night sleep latency &gt; 30 minute ) , well clinically significant daytime distress impairment 1 week self assessment prior baseline . 4 . Has complete 8th grade fluent English . 5 . If female child bear potential , patient must nonpregnant either postmenopausal use approved birth control method . Acceptable birth control method include : history tubal ligation , male partner sterile , IUDs , birth control pills hormonal birth control method ( e.g. , birth control patch , DepoProvera injection ) , doublebarrier method ( e.g. , condom foam ) . 6 . Antidepressant medication allow patient stable dose least one month . 1 . Evidence traumatic injury , inflammatory rheumatic disease , infectious endocrinerelated arthropathy . 2 . Evidence primary sleep disorder ( e.g. , significant sleep disorder breathing ( central obstructive apnea ) , periodic limb movement disorder , REM sleep behavior disorder . 3 . Any current , clinically significant medical condition . 4 . Pregnancy . 5 . Meets DSMIV criterion bipolar disorder , psychotic disorder , organic brain syndrome , psychoactive substance abuse dependence . 6 . Any current psychiatric disorder would interfere study participation ( investigator judgment ) . 7 . Active suicidal ideation . 8 . Plans engage additional psychotherapy study . 9 . Concurrent use benzodiazepines 6pm sleep aid . 10 . Concurrent use sleep aid . 11 . Concurrent use analgesic acetaminophen nonsteroidal antiinflammatory medication . 12 . Concurrent use medication stabilize least 1 month prior screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Fibromyalgia</keyword>
	<keyword>Insomnia</keyword>
	<keyword>Sleep</keyword>
	<keyword>Eszopiclone</keyword>
	<keyword>Lunesta</keyword>
</DOC>